88 related articles for article (PubMed ID: 15242808)
1. A novel cyclo-oxygenase-2 inhibitor modulates catabolic and antiinflammatory mediators in osteoarthritis.
Fernández P; Guillén MI; Gomar F; Aller E; Molina P; Alcaraz MJ
Biochem Pharmacol; 2004 Aug; 68(3):417-21. PubMed ID: 15242808
[TBL] [Abstract][Full Text] [Related]
2. Cyclooxygenase 2-dependent prostaglandin E2 modulates cartilage proteoglycan degradation in human osteoarthritis explants.
Hardy MM; Seibert K; Manning PT; Currie MG; Woerner BM; Edwards D; Koki A; Tripp CS
Arthritis Rheum; 2002 Jul; 46(7):1789-803. PubMed ID: 12124863
[TBL] [Abstract][Full Text] [Related]
3. A novel indazolo-triazolo-benzotriazepine exerts anti-inflammatory effects by inhibition of cyclooxygenase-2 activity and nitric oxide synthase-2 expression.
Fernández P; Guillén MI; Ubeda A; López-Cremades P; Aller E; Lorenzo A; Molina P; Alcaraz MJ
Naunyn Schmiedebergs Arch Pharmacol; 2003 Jul; 368(1):26-32. PubMed ID: 12827217
[TBL] [Abstract][Full Text] [Related]
4. Differential direct effects of cyclo-oxygenase-1/2 inhibition on proteoglycan turnover of human osteoarthritic cartilage: an in vitro study.
Mastbergen SC; Jansen NW; Bijlsma JW; Lafeber FP
Arthritis Res Ther; 2006; 8(1):R2. PubMed ID: 16356188
[TBL] [Abstract][Full Text] [Related]
5. [The effect of cyclooxygenase inhibitors on the bone and cartilage].
Burdan F
Pol Merkur Lekarski; 2005 Jun; 18(108):709-11. PubMed ID: 16124389
[TBL] [Abstract][Full Text] [Related]
6. Dose-dependent immunomodulatory effects of acetylsalicylic acid and indomethacin in human whole blood: potential role of cyclooxygenase-2 inhibition.
Härtel C; von Puttkamer J; Gallner F; Strunk T; Schultz C
Scand J Immunol; 2004 Oct; 60(4):412-20. PubMed ID: 15379866
[TBL] [Abstract][Full Text] [Related]
7. Suppression of NF-kappaB activation by curcumin leads to inhibition of expression of cyclo-oxygenase-2 and matrix metalloproteinase-9 in human articular chondrocytes: Implications for the treatment of osteoarthritis.
Shakibaei M; John T; Schulze-Tanzil G; Lehmann I; Mobasheri A
Biochem Pharmacol; 2007 May; 73(9):1434-45. PubMed ID: 17291458
[TBL] [Abstract][Full Text] [Related]
8. Regulation of the expression of 5-lipoxygenase-activating protein/5-lipoxygenase and the synthesis of leukotriene B(4) in osteoarthritic chondrocytes: role of transforming growth factor beta and eicosanoids.
Martel-Pelletier J; Mineau F; Fahmi H; Laufer S; Reboul P; Boileau C; Lavigne M; Pelletier JP
Arthritis Rheum; 2004 Dec; 50(12):3925-33. PubMed ID: 15593193
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-1beta induced activation of nuclear factor-kappab can be inhibited by novel pharmacological agents in osteoarthritis.
Lauder SN; Carty SM; Carpenter CE; Hill RJ; Talamas F; Bondeson J; Brennan P; Williams AS
Rheumatology (Oxford); 2007 May; 46(5):752-8. PubMed ID: 17218328
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and mechanism of action of KHBJ-9B, a new herbal medicine, and its major compound triterpenoids in human cartilage culture and in a rabbit model of collagenase-induced osteoarthritis.
Huh JE; Baek YH; Ryu SR; Lee JD; Choi DY; Park DS
Int Immunopharmacol; 2009 Feb; 9(2):230-40. PubMed ID: 19100343
[TBL] [Abstract][Full Text] [Related]
11. [Cyclo-oxygenase 2 inhibitors and cancer].
André T; Soria JC
Bull Cancer; 2004 May; 91 Spec No():S59-60. PubMed ID: 15239332
[No Abstract] [Full Text] [Related]
12. Reduced incidence of upper gastrointestinal ulcer complications with the COX-2 selective inhibitor, valdecoxib.
Goldstein JL; Eisen GM; Agrawal N; Stenson WF; Kent JD; Verburg KM
Aliment Pharmacol Ther; 2004 Sep; 20(5):527-38. PubMed ID: 15339324
[TBL] [Abstract][Full Text] [Related]
13. Impact of prolonged cyclooxygenase-2 inhibition on inflammatory markers and endothelial function in patients with ischemic heart disease and raised C-reactive protein: a randomized placebo-controlled study.
Bogaty P; Brophy JM; Noel M; Boyer L; Simard S; Bertrand F; Dagenais GR
Circulation; 2004 Aug; 110(8):934-9. PubMed ID: 15302800
[TBL] [Abstract][Full Text] [Related]
14. Effect of non-selective, non-steroidal anti-inflammatory drugs and cyclo-oxygenase-2 selective inhibitors on the PFA-100 closure time.
Blaicher AM; Landsteiner HT; Zwerina J; Leitgeb U; Volf I; Hoerauf K
Anaesthesia; 2004 Nov; 59(11):1100-3. PubMed ID: 15479319
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and evaluation of S-4-(3-thienyl)phenyl-alpha-methylacetic acid.
Mittal S; Malde A; Selvam C; Arun KH; Johar PS; Jachak SM; Ramarao P; Bharatam PV; Chawla HP
Bioorg Med Chem Lett; 2004 Feb; 14(4):979-82. PubMed ID: 15013005
[TBL] [Abstract][Full Text] [Related]
16. Effects of TGF-beta, TNF-alpha, IL-beta and IL-6 alone or in combination, and tyrosine kinase inhibitor on cyclooxygenase expression, prostaglandin E2 production and bone resorption in mouse calvarial bone cells.
Park YG; Kang SK; Kim WJ; Lee YC; Kim CH
Int J Biochem Cell Biol; 2004 Nov; 36(11):2270-80. PubMed ID: 15313472
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-1beta-induced extracellular matrix degradation and glycosaminoglycan release is inhibited by curcumin in an explant model of cartilage inflammation.
Clutterbuck AL; Mobasheri A; Shakibaei M; Allaway D; Harris P
Ann N Y Acad Sci; 2009 Aug; 1171():428-35. PubMed ID: 19723086
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-1beta-induced mucin production in human airway epithelium is mediated by cyclooxygenase-2, prostaglandin E2 receptors, and cyclic AMP-protein kinase A signaling.
Gray T; Nettesheim P; Loftin C; Koo JS; Bonner J; Peddada S; Langenbach R
Mol Pharmacol; 2004 Aug; 66(2):337-46. PubMed ID: 15266025
[TBL] [Abstract][Full Text] [Related]
19. Cyclooxygenase-2 is expressed in neuroblastoma, and nonsteroidal anti-inflammatory drugs induce apoptosis and inhibit tumor growth in vivo.
Johnsen JI; Lindskog M; Ponthan F; Pettersen I; Elfman L; Orrego A; Sveinbjörnsson B; Kogner P
Cancer Res; 2004 Oct; 64(20):7210-5. PubMed ID: 15492235
[TBL] [Abstract][Full Text] [Related]
20. [Specific cyclo-oxygenase-2 inhibitors in cardiovascular pathology].
Monsuez JJ
Arch Mal Coeur Vaiss; 2004 Jun; 97(6):632-40. PubMed ID: 15283037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
